Gilead Sciences funds community-based HIV prevention and anti-stigma projects for Black cisgender and Transgender women and girls in the U.S., using arts, advocacy, and education to improve health equity.
Funder: Gilead Sciences
Due Dates (Anticipated): June 2026 (Full application deadline, projected)
Funding Amounts: Funding levels are not specified; details provided on the initiative’s official site.
Summary: Supports HIV prevention, anti-stigma, and health equity efforts for Black cisgender and Transgender women and girls in the U.S. through arts, advocacy, community, and education approaches.
This initiative from Gilead Sciences aims to address HIV prevention, reduce stigma, and advance health equity specifically for Black cisgender and Transgender women and girls in the United States. The program supports community-based projects that leverage arts, advocacy, community engagement, and education to tackle HIV-related and identity-based stigma and reduce disparities affecting these communities.